The value of innovation.
Macias
William L
WL
Lilly Research Laboratories, Indianapolis, USA.
Levy
Howard
H
D000890:Anti-Infective Agents / Q000627:therapeutic use; D017326:Clinical Trials, Phase III as Topic; D003362:Cost-Benefit Analysis; D004059:Diffusion of Innovation; D006801:Humans; D011486:Protein C / Q000627:therapeutic use; D011994:Recombinant Proteins / Q000627:therapeutic use; D018805:Sepsis / Q000188:drug therapy*; D016019:Survival Analysis
D000890:Anti-Infective Agents; D011486:Protein C; D011994:Recombinant Proteins; C421124:drotrecogin alfa activated